Susan Hasty, Publisher
Table of Contents . . . October 7th, 1996Non-Subscriber - Summaries Only
Plasma Cell Tumors - Tumors Amenable to HSVtk/GCV Suicide Gene Therapy
Antisense Technology - Compound Biological Activity Reported in Several Types of Cancer
Bioengineering - Use of Cultured Human Keratinocytes to Treat Genetic Disorders
Cancer Vaccines - Irradiation Does Not Inhibit the Immunotherapeutic Response
Genetic Testing - BRACAnalysis Test Introduced for Breast and Ovarian Cancers
Industry News (Joint Venture) - Agreement Signed To Develop Leptin Gene Regulation Therapeutics
Industry News (Joint Ventures) - Agreement Involves Gene Repair Technology
Plasmodium falciparum (Genetics) - 35 kb Circle from Malaria Parasite Is Sequenced
Plasmodium falciparum (Genetics) - Subtelomeric Location of var Genes Has Implications for Antigenic Variants
Vectors (Development) - Generation of Retroviral Vectors Facilitated by VSV-G Protein Expression
Diagnostics (Mycobacterium) - "Identification of A M. kansasii Specific DNA Fragment."
Immunotherapy (HSV) - "Immunotherapy of Recurrent Genital Herpes with a Recombinant Glycoprotein Vaccine."
Pathogenesis (Strep) - "The Molecular Basis for Virulence."
Vaccine Development - "A Novel Multi-Epitope Vaccine Produced By Introducing Membrane Vesicles From Gram-Negative Pathogens Into Live Attenuated Salmonella typhi Ty21a Elicits A Strong Immune Response In A Mouse Model Syst
Antisense Technology - "Malignant Conversion of Human Cells by Antisense cDNA to a Putative Tumor Suppressor Gene."
Cancer Gene Therapy - "Selective in vitro Replication of Herpes Simplex Virus Type 1 (HSV-1) ICP34.5 Null Mutants in Primary Human CNS Tumours - Evaluation of a Potentially Effective Clinical Therapy."
X-Linked Disease - "High-Level Reconstitution of Respiratory Burst Activity in a Human X-Linked Chronic Granulomatous Disease (X-CGD) Cell Line and Correction of Murine X-CGD Bone Marrow Cells by Retrovir
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.